Warning: The NCBI web site requires JavaScript to function. more...
Interferon-induced versus chemokine transcripts as lupus biomarkers.
Crow MK, Kirou KA.
Arthritis Res Ther. 2008;10(6):126. Epub 2008 Dec 18.
Related citations
Association of elevated transcript levels of interferon-inducible chemokines with disease activity and organ damage in systemic lupus erythematosus patients.
Fu Q, Chen X, Cui H, Guo Y, Chen J, Shen N, Bao C.
Arthritis Res Ther. 2008;10(5):R112. Epub 2008 Sep 15.
Interferon-regulated chemokines as biomarkers of systemic lupus erythematosus disease activity: a validation study.
Bauer JW, Petri M, Batliwalla FM, Koeuth T, Wilson J, Slattery C, Panoskaltsis-Mortari A, Gregersen PK, Behrens TW, Baechler EC.
Arthritis Rheum. 2009 Oct;60(10):3098-107.
Type I interferon in systemic lupus erythematosus.
Crow MK.
Curr Top Microbiol Immunol. 2007;316:359-86. Review.
Interferon-alpha: a therapeutic target in systemic lupus erythematosus.
Rheum Dis Clin North Am. 2010 Feb;36(1):173-86, x.
Elevated serum levels of interferon-regulated chemokines are biomarkers for active human systemic lupus erythematosus.
Bauer JW, Baechler EC, Petri M, Batliwalla FM, Crawford D, Ortmann WA, Espe KJ, Li W, Patel DD, Gregersen PK, Behrens TW.
PLoS Med. 2006 Dec;3(12):e491.
The emerging role of interferon in human systemic lupus erythematosus.
Baechler EC, Gregersen PK, Behrens TW.
Curr Opin Immunol. 2004 Dec;16(6):801-7. Review.
Biomarkers for systemic lupus erythematosus: a review and perspective.
Liu CC, Manzi S, Ahearn JM.
Curr Opin Rheumatol. 2005 Sep;17(5):543-9. Review.
Chemokines in lupus nephritis.
Kulkarni O, Anders HJ.
Front Biosci. 2008 May 1;13:3312-20. Review.
Type I interferon-associated cytotoxic inflammation in cutaneous lupus erythematosus.
Wenzel J, Zahn S, Bieber T, Tüting T.
Arch Dermatol Res. 2009 Jan;301(1):83-6. Epub 2008 Sep 11. Review.
Epigenetic perspectives in systemic lupus erythematosus: pathogenesis, biomarkers, and therapeutic potentials.
Zhao S, Long H, Lu Q.
Clin Rev Allergy Immunol. 2010 Aug;39(1):3-9. Review.
Neutralization of interferon-alpha/beta-inducible genes and downstream effect in a phase I trial of an anti-interferon-alpha monoclonal antibody in systemic lupus erythematosus.
Yao Y, Richman L, Higgs BW, Morehouse CA, de los Reyes M, Brohawn P, Zhang J, White B, Coyle AJ, Kiener PA, Jallal B.
Arthritis Rheum. 2009 Jun;60(6):1785-96.
Multiplexed assays for identification of biomarkers and surrogate markers in systemic lupus erythematosus.
Utz PJ.
Lupus. 2004;13(5):304-11. Review.
A new tool for detection of type I interferon activation in systemic lupus erythematosus.
Kirou KA, Kalliolias GD.
Arthritis Res Ther. 2010;12(4):138. Epub 2010 Aug 26.
Cytokines and their receptors as biomarkers of systemic lupus erythematosus.
Suh CH, Kim HA.
Expert Rev Mol Diagn. 2008 Mar;8(2):189-98. Review.
Chemokines in systemic lupus erythematosus involving the central nervous system.
Kasama T, Odai T, Wakabayashi K, Yajima N, Miwa Y.
Front Biosci. 2008 Jan 1;13:2527-36. Review.
Systemic lupus erythematosus - a state of hyperinterferonemia?
Weinberger A, Aderka D, Pinkhas J.
Med Hypotheses. 1982 Oct;9(4):369-73.
Genetics of clinical expression in SLE.
Namjou B, Kilpatrick J, Harley JB.
Autoimmunity. 2007 Dec;40(8):602-12. Review.
Biomarkers in systemic lupus erythematosus.
Illei GG, Lipsky PE.
Curr Rheumatol Rep. 2004 Oct;6(5):382-90. Review.
Interferon alpha in systemic lupus erythematosus.
Niewold TB, Clark DN, Salloum R, Poole BD.
J Biomed Biotechnol. 2010;2010:948364. Epub 2010 Jun 29. Review.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on